2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lymphoma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma, Non-Hodgkin
17
Neuroblastoma
16
Leukemia, Myeloid, Acute
14
Leukemia
13
Hodgkin Disease
13
Central Nervous System Neoplasms
13
Small Cell Lung Carcinoma
10
Sarcoma
9
Brain Neoplasms
9
Recurrence
8
Medulloblastoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Rhabdoid Tumor
7
Multiple Myeloma
7
Lymphoma, B-Cell
7
Lung Neoplasms
7
Burkitt Lymphoma
7
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Astrocytoma
6
Teratoma
5
Ovarian Neoplasms
5
Neoplasms, Germ Cell and Embryonal
5
Neoplasms
5
Glioma
5
Interventions
pembrolizumab
14
Injections
13
Paclitaxel
10
Nivolumab
10
Docetaxel
9
Cisplatin
9
Capecitabine
9
Bevacizumab
8
toripalimab
7
senaparib
7
Fluorodeoxyglucose F18
7
Cyclophosphamide
7
tislelizumab
6
atezolizumab
6
Irinotecan
6
Fluorouracil
6
Gemcitabine
5
fludarabine
4
apatinib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Carboplatin
4
spartalizumab
3
sintilimab
3
pertuzumab
3
olaparib
3
camrelizumab
3
Rifampin
3
Radiosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solid Tumor
×
etoposide phosphate
×
Clear all
NCT04469530
2026-02-27
AflacST1903
Emory University
Phase 2
Recruiting
55 enrolled